Rerefined model
PDB 4B6L|dpdb_v1yqqpzc
Rerefined model
Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design
- Program
- PHENIX 2.0_5824
- Model type
- Multiconformer
- Purpose
- Refinement
- Atoms
- 2,547
- Residues
- 281
- Protein chains
- 1
- Alternate-location fraction
- 0%
- Ligands
- 9ZP, SO4
Evaluations
R-work
0.229
R-free
0.275
Clashscore
6.3
Macromolecules
The same in every model of this entry.
Data
L0 Raw
L1 Processed
L2 Models
L3 Evaluations